{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:11:41Z","timestamp":1779275501901,"version":"3.51.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>Gallbladder (GB) cancer is highly prevalent and fatal in South Korea. In operable patients, radical resection with an R0 margin combined with lymphadenectomy is the mainstay of curative-intent therapy. Despite R0 resection, a high recurrence rate has been observed, necessitating the identification of risk factors for recurrence after surgery. This study aimed to identify risk factors strongly related to recurrence after R0 resection of GB cancer. This single-center, retrospective cohort study included 148 patients with GB cancer who underwent R0 resection between January 1, 2014, and December 31, 2019. Variables were analyzed using statistical tools to identify risk factors related to prognosis. Early recurrence, disease progression within 1 year after R0 resection, relapse-free survival, and time from treatment to any event were analyzed with logistic regression and Cox regression analyses. Early recurrence was observed in 15.5% (N\u2005=\u200523) of patients. Based on statistical analysis, the independent risk factors for early recurrence and relapse-free survival were age\u2005&gt;\u200565 years, glycated hemoglobin level\u2005&gt;\u20056.5%, surgical T stage\u2005&gt;\u2005T3, surgical N stage\u2005&gt;\u2005N1, moderate or poor pathological differentiation, reversed albumin\u2013globulin ratio, high C-reactive protein level, and high carbohydrate antigen 19-9 level. Advanced pathological stage and high inflammatory marker levels, reflecting high tumor burden, are associated with poor prognosis. High glycated hemoglobin levels were also associated with early recurrence. In conclusion, active screening for early detection, reduction of inflammatory conditions, and management of diabetes may reduce early recurrence after R0 resection of GB cancer.<\/jats:p>","DOI":"10.1097\/md.0000000000045648","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:51Z","timestamp":1763571711000},"page":"e45648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative risk factors for early recurrence and relapse-free survival after R0 resection of gallbladder cancer"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-2148","authenticated-orcid":false,"given":"Sang Hun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-7753","authenticated-orcid":false,"given":"Dong Uk","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4627-5275","authenticated-orcid":false,"given":"Young Mi","family":"Seol","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archsurg.1996.01430210079015","article-title":"Gallbladder carcinoma in the era of laparoscopic cholecystectomy.","volume":"131","author":"Yamaguchi","year":"1996","journal-title":"Arch Surg"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors.","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jso.25825","article-title":"Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: an analysis of the US extrahepatic biliary malignancy consortium.","volume":"121","author":"Sahara","year":"2020","journal-title":"J Surg Oncol"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"issue":"Suppl 4","key":"R6-20260520","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/10.suppl_4.S308","article-title":"Risk factors for biliary tract carcinogenesis.","volume":"10","author":"Chapman","year":"1999","journal-title":"Ann Oncol"},{"key":"R7-20260520","first-page":"255","article-title":"Translating cancer genomics for precision oncology in biliary tract cancers.","volume":"28","author":"Haber","year":"2019","journal-title":"Discov Med"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2893.2009.01243.x","article-title":"Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.","volume":"17","author":"Tanaka","year":"2010","journal-title":"J Viral Hepat"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-107-1-30","article-title":"Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota.","volume":"107","author":"Maringhini","year":"1987","journal-title":"Ann Intern Med"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2168.1999.01085.x","article-title":"Treatment of gallbladder cancer by radical resection.","volume":"86","author":"Todoroki","year":"1999","journal-title":"Br J Surg"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1007302","article-title":"Recent advances in the management of cholangiocarcinomas.","volume":"14","author":"Vauthey","year":"1994","journal-title":"Semin Liver Dis"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer.","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.gastha.2022.04.007","article-title":"Worldwide incidence and mortality of biliary tract cancer.","volume":"1","author":"Baria","year":"2022","journal-title":"Gastro Hep Advances"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21037\/cco.2016.10.03","article-title":"Surgical management of biliary tract cancers.","volume":"5","author":"Fairweather","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma.","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors.","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries.","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"key":"R23-20260520","first-page":"1159","article-title":"Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma \u2013 focus on East and South-Eastern Asia.","volume":"11","author":"Shin","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4166\/kjg.2021.411","article-title":"Gender difference in gallbladder cancer: focusing on the clinical characteristics, treatment, and prognosis of Korean patients.","volume":"78","author":"Kim","year":"2021","journal-title":"Korean J Gastroenterol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","article-title":"Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.","volume":"14","author":"Kim","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/03007995.2018.1479683","article-title":"Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients.","volume":"35","author":"Bozkaya","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7754\/Clin.Lab.2023.230528","article-title":"De Ritis ratio: a potent marker in cancer.","volume":"69","author":"Li","year":"2023","journal-title":"Clin Lab"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CMAR.S342674","article-title":"Prediction of early recurrence after R0 resection for gallbladder carcinoma of Stage T1b\u2013T3.","volume":"14","author":"Peng","year":"2022","journal-title":"Cancer Manag Res"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00595-013-0622-5","article-title":"Correlation between preoperative systemic inflammation and postoperative infection in patients with gastrointestinal cancer: a multicenter study.","volume":"44","author":"Mohri","year":"2014","journal-title":"Surg Today"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjsurg.2017.04.007","article-title":"Clinical burden of preoperative albumin\u2013globulin ratio in esophageal cancer patients.","volume":"214","author":"Oki","year":"2017","journal-title":"Am J Surg"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ijc.29659","article-title":"\u03b3-Glutamyltransferase and cancer risk: the Korean cancer prevention study.","volume":"138","author":"Mok","year":"2016","journal-title":"Int J Cancer"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12916-022-02506-x","article-title":"C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis.","volume":"20","author":"Zhu","year":"2022","journal-title":"BMC Med"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: biochemical and clinical aspects.","volume":"867","author":"Scar\u00e0","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CEJ.0b013e3283481d89","article-title":"Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.","volume":"21","author":"Jing","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"R36-20260520","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.bjc.6604765","article-title":"The antecedents of biliary cancer: a primary care case\u2013control study in the United Kingdom.","volume":"100","author":"Grainge","year":"2009","journal-title":"Br J Cancer"},{"key":"R37-20260520","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-021-02884-x","article-title":"Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.","volume":"74","author":"Mili","year":"2021","journal-title":"Endocrine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:02:12Z","timestamp":1779274932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":36,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045648","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2024-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}